Patel Samir Rashmikant
SEC insider (Form 3/4/5 filer). CIK 0001702447. Director at Akari Therapeutics Plc (AKTX). 23 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in TAMPA, FL.
Companies Patel Samir Rashmikant has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director
Patel Samir Rashmikant
CIK: 0001702447
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akari Therapeutics Plc
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 5, 2026AKTX
Akari Therapeutics Plc
AwardDirect2.2K shares at avg. $7.90$18K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirect6.3K shares at avg. $7.90$50K - Jul 7, 2026AKTX
Akari Therapeutics Plc
ExerciseIndirect5.8K shares at avg. $0.00$2.32 - Jul 7, 2026AKTX
Akari Therapeutics Plc
ExerciseIndirect1.2K shares at avg. $8.00$10K - Jul 7, 2026AKTX
Akari Therapeutics Plc
ExerciseIndirect15.5K shares at avg. $0.00$6.186 - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseIndirectPre-Funded Warrants to purchase ADRs
232K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
618.7K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
618.7K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseIndirectWarrants to purchase ADRs
232K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
175K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | AKTX Akari Therapeutics Plc | Award | 2,236 | $7.90 | $17,662 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award | 6,300 | $7.90 | $49,764 | Direct |
| Jul 7, 2026 | AKTX Akari Therapeutics Plc | Exercise | 5,799 | $0.00 | $2 | Indirect |
| Jul 7, 2026 | AKTX Akari Therapeutics Plc | Exercise | 1,209 | $8.00 | $9,672 | Indirect |
| Jul 7, 2026 | AKTX Akari Therapeutics Plc | Exercise | 15,466 | $0.00 | $6 | Indirect |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 231,997 | $0.40 | - | Indirect |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 231,997 | - | - | Indirect |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 175,000 | - | - | Direct |
1-10 of 23 transactions